IL126064A0 - Method for treating pain - Google Patents

Method for treating pain

Info

Publication number
IL126064A0
IL126064A0 IL12606497A IL12606497A IL126064A0 IL 126064 A0 IL126064 A0 IL 126064A0 IL 12606497 A IL12606497 A IL 12606497A IL 12606497 A IL12606497 A IL 12606497A IL 126064 A0 IL126064 A0 IL 126064A0
Authority
IL
Israel
Prior art keywords
treating pain
pain
treating
Prior art date
Application number
IL12606497A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL126064A0 publication Critical patent/IL126064A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12606497A 1996-03-25 1997-03-24 Method for treating pain IL126064A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US1413396P 1996-03-25 1996-03-25
US1415396P 1996-03-25 1996-03-25
US1413196P 1996-03-25 1996-03-25
PCT/US1997/004626 WO1997035583A1 (en) 1996-03-25 1997-03-24 Method for treating pain

Publications (1)

Publication Number Publication Date
IL126064A0 true IL126064A0 (en) 1999-05-09

Family

ID=27360028

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12606497A IL126064A0 (en) 1996-03-25 1997-03-24 Method for treating pain

Country Status (14)

Country Link
US (1) US6258807B1 (xx)
EP (1) EP0910381A4 (xx)
JP (1) JP2001517202A (xx)
CN (1) CN1219878A (xx)
AU (1) AU721338B2 (xx)
BR (1) BR9708246A (xx)
CA (1) CA2248873A1 (xx)
CZ (1) CZ298198A3 (xx)
EA (1) EA199800866A1 (xx)
IL (1) IL126064A0 (xx)
NO (1) NO984446L (xx)
PL (1) PL329217A1 (xx)
WO (1) WO1997035583A1 (xx)
YU (1) YU42298A (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ296263B6 (cs) * 1996-03-25 2006-02-15 Eli Lilly And Company Farmaceutická kompozice pro lécení bolesti a jejípouzití
JP2000507546A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 麻酔方法
CN101371843B (zh) 2002-11-26 2012-09-26 艾利斯达医药品公司 洛沙平和阿莫沙平在制备治疗疼痛的药物中的应用
NZ540208A (en) * 2002-11-26 2007-09-28 Alexza Pharmaceuticals Inc Treatment of headache with antipsychotics delivered by inhalation
JP4964593B2 (ja) * 2003-09-25 2012-07-04 セノメド バイオサイエンシーズ，エルエルシー 神経学的病状の治療用のテトラヒドロインドロン誘導体
US20050107439A1 (en) * 2003-11-10 2005-05-19 Helton David R. Composition and method for treating emesis
US7402777B2 (en) 2004-05-20 2008-07-22 Alexza Pharmaceuticals, Inc. Stable initiator compositions and igniters
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
WO2009062134A1 (en) * 2007-11-09 2009-05-14 Cenomed Biosciences, Llc Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
US20090264443A1 (en) * 2008-04-18 2009-10-22 David Helton Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
US20150190403A1 (en) 2012-07-31 2015-07-09 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Use of olanzapine in animals
US20150216206A1 (en) 2012-07-31 2015-08-06 Sanovel Hayvan Sagligi Urunleri Sanayi Ve Ticaret Anonim Sirketi Method for increasing meat and milk production
CN106243096B (zh) * 2016-07-29 2019-11-29 上海璃道医药科技有限公司 三环类药物的新用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994924A (en) * 1975-11-04 1976-11-30 American Cyanamid Company 4,5,6,7-Tetra hydro-7-oxobenzo(B)thien-4-yl isocyanate and isothiocyanate
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
DK203990D0 (da) * 1990-08-24 1990-08-24 Novo Nordisk As Piperazinylderivater
DE69329887T2 (de) * 1992-05-29 2001-05-23 Eli Lilly And Co., Ltd. Thienobenzodiazepinderivate zur Behandlung von Störungen des Zentralnervensystems
US5457101A (en) 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
US5605911A (en) * 1995-01-31 1997-02-25 Washington University Use of alpha-2 adrenergic drugs to prevent adverse effects of NMDA receptor hypofunction (NRH)
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
JP2000507546A (ja) * 1996-03-25 2000-06-20 イーライ・リリー・アンド・カンパニー 麻酔方法
IL126063A (en) * 1996-03-25 2002-04-21 Lilly Co Eli Medicinal products containing ulanzapine for the treatment of migraine pain
CZ296263B6 (cs) * 1996-03-25 2006-02-15 Eli Lilly And Company Farmaceutická kompozice pro lécení bolesti a jejípouzití

Also Published As

Publication number Publication date
CA2248873A1 (en) 1997-10-02
EA199800866A1 (ru) 1999-06-24
US6258807B1 (en) 2001-07-10
WO1997035583A1 (en) 1997-10-02
JP2001517202A (ja) 2001-10-02
PL329217A1 (en) 1999-03-15
BR9708246A (pt) 1999-07-27
CZ298198A3 (cs) 1999-06-16
CN1219878A (zh) 1999-06-16
EP0910381A1 (en) 1999-04-28
YU42298A (sh) 1999-09-27
AU2340897A (en) 1997-10-17
NO984446D0 (no) 1998-09-24
EP0910381A4 (en) 2002-10-09
AU721338B2 (en) 2000-06-29
NO984446L (no) 1998-11-25

Similar Documents

Publication Publication Date Title
IL126203A0 (en) Method for treating pain
EP0906104A4 (en) PAIN TREATMENT PROCESS
AU9035498A (en) Method for treating pain
EP0792371A4 (en) COMBINED ACNE TREATMENT PROCESS
SG50018A1 (en) Method for developing treatment
GB9617780D0 (en) Method of treatment
EP0946180A4 (en) METHODS FOR STIMULATING BONE FORMATION
IL126759A0 (en) Method for treating inflammation
IL126064A0 (en) Method for treating pain
GB9605828D0 (en) Treatment method
IL126063A0 (en) Method for treating migraine pain
IL124786A0 (en) Method for treating pain
AU9034798A (en) Method for treating pain
EP0889725A4 (en) METHOD FOR TREATING BIPOLAR DISORDERS
GB9714841D0 (en) Treatment method
ZA973988B (en) Method of treatment
GB9618341D0 (en) Method of treatment
EP0786999A4 (en) COMBINED ACNE TREATMENT PROCESS
ZA971899B (en) Method for treating insomnia
IL126160A0 (en) Method for treating insomnia
GB9600610D0 (en) Treatment method
GB9614742D0 (en) Treatment method
GB9614741D0 (en) Treatment method
GB9614743D0 (en) Treatment method
KR970006505B1 (en) Waste treatment method